Prostate cancer and novel pharmacological treatment options-what's new for 2022?
Andrea MarchettiElisa TassinariMatteo RoselliniAlessandro RizzoFrancesco MassariVeronica Mollica
Published in: Expert review of clinical pharmacology (2023)
Lu-PSMA-617 proved successful outcomes in pretreated mCRPC patients. Additional studies will better clarify the appropriate candidates to each strategy and the correct treatments' sequence.